Study of Phytochemical Composition of Generative Organs of Standardized Drug Raw Material Crocus Sativus L
crocus sativus, hexane extract, benzene extract, chromatographic mass spectrophotometer
Abstract
The article is devoted to the study of the development of methods for standardization of medicinal plant raw materials for the preparation of conditions for the maximum production of biological active substances from seed saffron.
Downloads
How to Cite
References
F Abdullaev, J Espinosa-Aguirre (2004) Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. 28(6), 426-432.
F Abdullaev (2003) Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.) // Toxicology in vitro. 17, 751.
M Dashtir, F Zeinali, M Anvari, S Hosseini, Saffron (2012) Crocus sativus L.) extract prevents and improves d-galactose and NANO2 induced memory impairment in mice. 328-337.
E Guenther (1952) The essential oils. Vol. VI. By Ernest Guenther. D. Van Nostrand Company, Inc., New York, 1952. xvi + 481pp. Illustrated. 15.5 × 23.5cm. Price $9.75. 41(8), 456.
Richard Kuhn, Alfred Winterstein (1934) Über die Konstitution des Pikro‐crocins und seine Beziehung zu den Carotin‐Farbstoffen des Safrans. 67(2), 344-357.
G Kapinos (1965) Tuberous Medicinal Plants of India: Biology and Biotechnology. 319-345.
A Makhmudov (2016) Bioecological Features and anatomical Structure Crocus sativus L. to the Introduction in Uzbekistan. 5, 17-23.
Ehsan Karimi, Ehsan Oskoueian, Rudi Hendra, Hawa Jaafar (2010) Evaluation of Crocus sativus L. Stigma Phenolic and Flavonoid Compounds and Its Antioxidant Activity. 15(9), 6244-6256.
Published
2018-11-06
Issue
Section
License
Copyright (c) 2018 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.